Navigation Links
National Adverse Drug Event Network Launched
Date:6/14/2011

hnologies, Inc.

Greenway Medical Technologies provides innovative EHR, ambulatory healthcare and clinical research business solutions and services to more than 27,000 healthcare providers nationwide, in 31 specialties and subspecialties, by enhancing the delivery of patient care through advanced health IT software and on-demand services that allow physician practices to function at their highest level of efficiency in group practice, IDN, REC, HIE, IPA, Accountable Care Organization (ACO) and Patient Centered Medical Home (PCMH) settings. Established in 1998, Carrollton, Ga.-based Greenway is a privately held company with more than 450 employees.

About the American Pharmacists Association

The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 C6 organization, representing more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession. APhA, dedicated to helping all pharmacists improve medication use and advance patient care, is the first-established and largest association of pharmacists in the United States.

About athenahealth

athenahealth, Inc. is the leading provider of cloud-based business services for physician practices. athenahealth's service offerings are based on proprietary web-native practice management and electronic health record (EHR) software, a continuously updated payer knowledge-base, integrated back-office service operations, and automated and live patient communication services. For more information, please visit http://www.athenahealth.com/ or call (888) 652-8200.

About PDR Network

PDR Network, LLC is the leading distributor of FDA-approved drug labeling information, product safety Alerts and REMS programs, including the Physicians' Desk Reference® ("PDR"<
'/>"/>

SOURCE PDR Network
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. September is National Pain Awareness Month
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing ... announced that it has initiated dosing in a Phase ... oral therapy for the treatment of HCV infection. This study ... designed to assess both the safety and antiviral efficacy ... for the treatment of chronic HCV infections and is ...
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... DIEGO , May 23, 2013 ... today announced the appointment of David ... Mr. Ramsay was most recently Vice President, Corporate ... http://photos.prnewswire.com/prnh/20100302/LA63139LOGO )     "With his established financial ... experience gained by working in our commercial group ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2
... SEATTLE, May 2, 2011 CMC Biologics, a ... Copenhagen, Denmark and Seattle, Washington USA, announced today ... at its Chief Executive Officer. CMC Biologics, a ... world class, fully integrated, biopharmaceutical process development and ...
... SAN DIEGO, May 2, 2011 Volcano Corporation (NASDAQ: ... of precision intravascular diagnosis and therapy guidance tools designed ... disease, said today that it will be participating in ... May 10. The presentation by John Dahldorf, ...
Cached Medicine Technology:CMC Biologics Announces Appointment of New CEO 2
(Date:5/23/2013)... DC (PRWEB) May 23, 2013 “Talk. ... (PSA) campaign that empowers parents to talk to children ... of underage drinking, was launched today by the Substance ... The kickoff occurred in conjunction with SAMHSA’s 2013 National ... of, and action around, substance abuse and mental health ...
(Date:5/23/2013)... Live Lead Pros , with its ... business lead solution via its smart solution for ... features Free Web Based Account Management, Database Usage, ... "Automatic Transfer Retry". The company has recently announced ... system. , Its Free Database Usage offers their ...
(Date:5/23/2013)... anti-cancer drug about to be tested in a clinical ... possible treatment for Alzheimer,s disease has failed to work ... Alzheimer,s patients, according to results of a study by ... professor of neuroscience affiliated with the Evelyn F. and ... Florida, emphasized the importance of verifying promising research results ...
(Date:5/23/2013)... characterized as "triple negative" carries a poor prognosis, with ... kill the cancer cells the way it,s supposed to. ... cells don,t respond to chemotherapy, and identifies a mechanism ... Dr. Shawn Li, PhD, and his team at Western,s ... protein called Numb functions to promote the death of ...
(Date:5/23/2013)... New York, New York (PRWEB) May 23, 2013 ... products manufactured by C.R. Bard, Inc., continue to move ... District Court, Southern District of West Virginia, Bernstein Liebhard ... 17th, the Court denied a request by C.R. Bard ... claimed would reveal trade secrets and other confidential, proprietary ...
Breaking Medicine News(10 mins):Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3
... taken by European governments and healthcare authorities ... at improving efficiency levels and reducing expenditures. ... is proving to be a major challenge.(Logo: ... from governments across Europe to install infection ...
... Programs Supported by a Grant from Otsuka America ... quality of care and increasing awareness of and ... communities are all values held by the 2009 ... for Advancing Minority Mental Health.The awards, presented by ...
... 5 Nutrition 21, Inc. (Nasdaq: NXXI ), ... manage blood sugar levels, improve cardiovascular health, enhance memory and ... to the opening of the market - on Tuesday, May ... ended March 31, 2009. The Company has scheduled a conference ...
... Market for Women,s Health Devices Worth $2.1 Billion in ... research reports by iData Research ( www.idataresearch.net ) - ... firm - the U.S. market for female sterilization devices ... market, transcervical sterilization devices, which grew over 54% in ...
... $19.7 Million -- Same-Store Sales Increased 1.1% -- Net Cash ... Loss Improved 18.0% to $17.2 Million - , NEW YORK, ... results for the first quarter ended March 28, 2009. Key ... Adjusted FIFO EBITDA increased 7.8% to $19.7 ...
... coli, K. pneumoniae and P. aeruginosa Directly from ... Hours Sooner Than Conventional Methods to Help Clinicians ... Gram-Negative Bloodstream InfectionsWOBURN, Mass., and VEDBAEK, Denmark, May ... 510(k) clearance for EK/ P. aeruginosa PNA ...
Cached Medicine News:Health News:Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe 2Health News:Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe 3Health News:American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health 2Health News:American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health 3Health News:American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health 4Health News:Nutrition 21 to Report Third Quarter Fiscal Year 2009 Financial Results on Tuesday, May 12, 2009 2Health News:U.S. Market for Female Sterilization Devices to Grow 36% in 2009 2Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 2Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 3Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 4Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 5Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 6Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 7Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 8Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 9Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 10Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 11Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 12Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 13Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 14Health News:Duane Reade Holdings, Inc. Reports First Quarter 2009 Results 15Health News:AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R) 2Health News:AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R) 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: